| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |